A compound is tested for mutagenicity by adding it directly to bacteria. It shows no mutagenic activity. When the same compound is tested in the Ames test (which includes rat liver extract), it is highly mutagenic. What does this result tell you about the compound?
AThe compound is a direct-acting mutagen that is inactivated by the bacterial repair system
BThe compound requires metabolic activation by liver enzymes to become a reactive, DNA-damaging species
CThe compound is a physical mutagen that requires energy input to damage DNA
DThe compound is only mutagenic when combined with bacterial enzymes in the Ames test
This is precisely the scenario that reveals metabolic activation. Compounds like benzo[a]pyrene in cigarette smoke are not themselves reactive with DNA — they must first be converted by cytochrome P450 enzymes in the liver into reactive electrophiles that can form DNA adducts. The Ames test includes rat liver extract (S9 fraction) specifically to mimic this metabolic processing. A compound that is mutagenic only in the presence of liver extract is a pro-mutagen: harmless in its original form, dangerous after metabolism. This is why carcinogenicity testing cannot rely solely on direct toxicity assays — a substance may appear safe in vitro while being activated to a mutagen in the body.
Question 2 Multiple Choice
UV radiation causes thymine dimers in DNA. How do thymine dimers lead to mutations, given that accurate repair mechanisms exist for these lesions?
AThymine dimers directly change the base-pairing properties of the bases, causing immediate misincorporation during the same replication cycle
BWhen replication machinery encounters a thymine dimer and cannot read through it, error-prone translesion synthesis polymerases insert bases opposite the dimer, often incorrectly
CThymine dimers permanently block transcription and replication, so the cell must delete the damaged segment to survive
DThymine dimers cause double-strand breaks that are then misrepaired by non-homologous end joining
Nucleotide excision repair (NER) accurately removes and replaces thymine dimers when it functions correctly. The mutational risk arises when replication encounters a dimer before repair occurs: the replicative polymerase stalls, and the cell recruits translesion synthesis (TLS) polymerases to continue. These specialized polymerases lack the proofreading fidelity of normal replicative polymerases, and they frequently insert incorrect bases opposite the dimer — often AA opposite a TT dimer, which is actually non-mutagenic in some contexts, but sometimes incorrect bases — fixing the error as a permanent sequence change on subsequent replication. This illustrates the key principle: the lesion itself is not the mutation; the error-prone repair or bypass of the lesion is.
Question 3 True / False
Whether a given DNA lesion results in a permanent mutation depends not only on the mutagen that caused it, but also on which repair pathway processes it.
TTrue
FFalse
Answer: True
This is the central conceptual point about DNA damage versus mutation. A lesion — a chemical alteration to DNA — is not yet a mutation. It becomes a mutation only if it is either misrepaired (introducing an incorrect sequence during repair synthesis) or bypassed by an error-prone polymerase during replication. If accurate repair (NER, BER, or mismatch repair) acts first, the lesion is removed and the original sequence restored — no mutation results. The same adduct can thus produce a mutation in one cell (where repair was overwhelmed or bypassed) and leave no trace in another (where accurate repair acted promptly). Dose matters precisely because high doses overwhelm the repair machinery.
Question 4 True / False
Most carcinogens cause cancer by mutating DNA, so carcinogenicity and mutagenicity are equivalent properties of a chemical agent.
TTrue
FFalse
Answer: False
Some carcinogens operate through non-mutagenic mechanisms. Tumor promoters, for example, do not damage DNA directly but instead enhance proliferation of cells that have already accumulated mutations — promoting the expansion of pre-cancerous clones without introducing new mutations. Certain hormones, chronic inflammatory agents, and epigenetic modifiers can drive carcinogenesis through gene expression changes rather than sequence changes. A chemical can be mutagenic without being carcinogenic (if it mutates non-oncogenic loci) and carcinogenic without being mutagenic (if it promotes growth of existing mutant cells). These are distinct but overlapping properties, not synonyms.
Question 5 Short Answer
Why does the Ames test include rat liver extract, and what fundamental principle about mutagenesis does this design choice reflect?
Think about your answer, then reveal below.
Model answer: The Ames test includes rat liver extract (the S9 fraction, containing cytochrome P450 enzymes and other metabolic machinery) to mimic the metabolic processing that chemicals undergo in the body before reaching target tissues. Many mutagens are not reactive in their original chemical form — they are pro-mutagens that must be converted by liver enzymes into reactive electrophiles capable of forming DNA adducts. Without the liver extract, these pro-mutagens would test as negative in bacteria, producing false negatives. The design reflects the principle that mutagenicity must be evaluated after realistic metabolic transformation, not just for the parent compound. A substance that appears safe in direct cell toxicity assays may be activated to a potent mutagen by hepatic metabolism — precisely the scenario that drives occupational and dietary carcinogen risk.
This connects to the broader principle that the dose and route of exposure matter: a compound's mutagenic potential depends on what form it takes in the body, not just its original structure. The Ames test's inclusion of liver extract was a key methodological innovation that made it far more predictive of carcinogenic risk in mammals than earlier direct-testing assays.